About the Authors
- Naveed Sattar
-
Roles Writing – review & editing
* E-mail: Naveed.sattar@glasgow.ac.uk
Affiliation School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom
- Reshmi Srinath
-
Roles Writing – review & editing
Affiliation Icahn School of Medicine at Mount Sinai, New York, New York, United States of America
- Luis-Emilio García-Pérez
-
Roles Writing – review & editing
Affiliation Eli Lilly and Company, Indianapolis, Indiana, United States of America
- Clare J. Lee
-
Roles Writing – review & editing
Affiliation Eli Lilly and Company, Indianapolis, Indiana, United States of America
- Chrisanthi A. Karanikas
-
Roles Writing – original draft, Writing – review & editing
Affiliation Eli Lilly and Company, Indianapolis, Indiana, United States of America
- Xinyue Chen
-
Roles Formal analysis, Writing – review & editing
Affiliation Eli Lilly and Company, Indianapolis, Indiana, United States of America
- Arian Plat
-
Roles Supervision, Writing – original draft, Writing – review & editing
Affiliation Eli Lilly and Company, Indianapolis, Indiana, United States of America
Competing Interests
Naveed Sattar reports consulting and/or speaker fees from Abbott Laboratories, Abbvie, Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Hanmi Pharmaceuticals, Janssen, Menarini-Ricerche, Novartis, Novo Nordisk, Pfizer, Roche Diagnostics, and Sanofi; and grant support paid to his institution from AstraZeneca, Boehringer Ingelheim, Novartis, and Roche Diagnostics outside the submitted work. Reshmi Srinath declares no competing interests. Luis-Emilio Garcia-Perez, Clare J. Lee, Chrisanthi A. Karanikas, Xinyue Chen and Arian Plat are employees and shareholders at Eli Lilly and Company.